- Presentations
- 3
- Markets
- 1
Tafinlar is a brand of Dabrafenib marketed by Novartis Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Dabrafenib
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 50 mg capsule, 75 mg capsule, 10 mg tablet for oral suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tafinlar 50 mg capsuleOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Tafinlar 75 mg capsuleOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Tafinlar 10 mg tablet for oral suspensionOral | Novartis Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Tafinlar
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.